Ovation Diagnostics – Ovarian Cancer Detection

Ovation Diagnostics is dedicated to developing advanced and accessible ovarian cancer diagnostic technologies to address a global unmet need.

The Problem: Early Detection of Ovarian Cancer

• Ovarian cancer is the fifth leading cause of cancer induced death among women in the US
  • Women currently affected with ovarian cancer
    • In the US = 22,000
    • In the world = 180,000
• Prognosis is poor; 5 year survival is no better than 37%
• Current tests fail to provide reliable screening at stage I of ovarian cancer
• About 60% of women are being diagnosed after the disease has spread beyond the ovary

The Solution: Ovation Diagnostics

• Early diagnosis is critical to reduce the risk of death from ovarian cancer
• Screening of ovarian cancer is necessary to identify early stages of ovarian cancer
• Using a urine dipstick instead of diagnosing through blood samples will make screening easier
• Levels of a protein marker called Bcl-2 are elevated in the urine of patients with ovarian cancer and are of diagnostic and/or prognostic clinical importance
  • Prognosis is greater than 90% if identified in Stage 1
• Early diagnosis is critical to reduce the risk of death from ovarian

Find out more about Ovation Diagnostics